Anti-inflammatory PEGylated bilirubin microneedle patch for diabetes treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Salivary Gland Disorders and Functions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Type 2 diabetes – An autoinflammatory disease driven by metabolic stress10.1016/j.bbadis.2018.08.034 ↗
2. The significance of glutaredoxins for diabetes mellitus and its complications10.1016/j.redox.2024.103043 ↗
3. Genetics of diabetes mellitus and diabetes complications10.1038/s41581-020-0278-5 ↗
4. Pump-less, recirculating organ-on-chip (rOoC) platform to model the metabolic crosstalk between islets and liver
5. Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways
6. Early screening for metabolic syndrome opens a window of opportunity - learnings from a long-term, population-based study10.1093/eurheartj/ehad655.2373 ↗
7. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?10.1016/j.jhep.2017.09.021 ↗
8. Time to act: the challenge of high incidence of diabetes and prediabetes in patients admitted with different cardiovascular diseases phenotypes10.1093/eurheartj/ehad655.2551 ↗
9. Kidney subclinical lesions in hypertension phenotypes defined by Home Blood Pressure Monitoring among young adults enrolled in a Family Health Strategy unit10.1093/eurheartj/ehad655.2329 ↗
10. Kidney involvement in a nongenetic rat model of type 2 diabetes10.1111/j.1523-1755.2005.00727.x ↗
11. Oral multidrug co-delivery system targeting differential sites for diabetes mellitus treatment
12. Bio-inspired porous microneedles dwelled stem cells for diabetic wound treatment
13. COVID-19 and diabetes10.1146/annurev-med-042220-011857 ↗
14. The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 202010.1093/eurheartj/ehad655.2027 ↗
15. HAPPCAP-AD (Human-Application Combined Approach for Prevention of Alzheimer's Disease): a novel feasibility study of a personalized midlife intervention to prevent AD
16. Shifting of parvalbumin expression in the rat retina in experimentally induced diabetes10.1007/s00401-007-0314-6 ↗
17. Prevention and treatment of diabetic foot ulcers10.1177/0141076816688346 ↗
18. Can COVID-19 cause diabetes?10.1038/s42255-020-00339-7 ↗
19. Association of GLP-1 receptor agonists with chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes10.1164/rccm.202303-0491OC ↗
20. COVID-19-induced new onset diabetes mellitus10.1016/j.chest.2021.07.589 ↗
21. Inflammatory pathways in CVD and diabetes: broad-spectrum versus selective targeting10.1016/j.jacc.2018.04.093 ↗
22. Epidemiological studies of diabetes mellitus in Denmark: 4. Clinical characteristics of insulin-treated diabetes10.1007/BF00279934 ↗
23. Prevention of cardiorenal complications in people with type 2 diabetes and obesity10.1016/j.cmet.2023.12.018 ↗
24. Association Between caregiver strain and self-care among caregivers with diabetes10.1001/jamanetworkopen.2020.36676 ↗
25. Persistent medication adherence and lifestyle changes compliance in patients with type 2 diabetes undergoing minor foot amputation and one-year all-cause mortality10.1093/eurheartj/ehac544.1969 ↗
26. pH and glucose dual-responsive injectable hydrogels with insulin and fibroblasts as bioactive dressings for diabetic wound healing10.1021/acsami.7b09395 ↗
27. Erythrocyte-membrane-camouflaged nanoplatform for intravenous glucose-responsive insulin delivery
28. Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy10.1038/s41467-017-01764-1 ↗
29. Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery10.1016/j.jconrel.2022.10.044 ↗
30. Recent progress in design and preparation of glucose-responsive insulin delivery systems10.1016/j.jconrel.2020.02.014 ↗
31. Core-shell microneedle gel for self-regulated insulin delivery10.1021/acsnano.7b08152 ↗
32. Development of Cu nanoflowers modified the flexible needle-type microelectrode and its application in continuous monitoring glucose in vivo10.1016/j.bios.2018.03.024 ↗
33. Hyaluronate–gold nanoparticle/glucose oxidase complex for highly sensitive wireless noninvasive glucose sensors10.1021/acsami.9b13874 ↗
34. An engineered nanosugar enables rapid and sustained glucose-responsive insulin delivery in diabetic mice
35. Microneedle patches loaded with nanovesicles for glucose transporter-mediated insulin delivery10.1021/acsnano.2c05687 ↗
36. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery10.1021/acs.nanolett.6b03848 ↗
37. Synthesis, characterization of copper oxide-gold nanoalloys and their peroxidase-like activity towards colorimetric detection of hydrogen peroxide and glucose10.1016/j.msec.2018.12.010 ↗
38. The role of the inflammatory and the vascular pathogenesis in a model of streptozotocin induced diabetic neuropathy in rats
39. Organosilica-based hollow mesoporous bilirubin nanoparticles for antioxidation-activated self-protection and tumor-specific deoxygenation-driven synergistic therapy10.1021/acsnano.9b02477 ↗
40. Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis10.1038/s41563-019-0462-9 ↗
41. Pharmacological actions and therapeutic potentials of bilirubin in islet transplantation for the treatment of diabetes10.1016/j.phrs.2019.104256 ↗
42. A wirelessly controlled smart bandage with 3D-printed miniaturized needle arrays10.1002/adfm.201905544 ↗
43. Plasmonic paper microneedle patch for on-patch detection of molecules in dermal interstitial fluid10.1021/acssensors.9b00258 ↗
44. The clinical and translational prospects of microneedle devices, with a focus on insulin therapy for diabetes mellitus as a case study10.1016/j.ijpharm.2022.122234 ↗
45. 3D-printed microneedle arrays for drug delivery10.1016/j.jconrel.2022.08.022 ↗
46. Long-acting microneedle formulations10.1016/j.addr.2023.115055 ↗
47. Microneedle, bio-microneedle and bio-inspired microneedle: a review10.1016/j.jconrel.2017.02.011 ↗
48. Construction of microneedle-assisted co-delivery platform and its combining photodynamic/immunotherapy10.1016/j.jconrel.2020.05.006 ↗
49. Hyalase-mediated cascade degradation of a matrix barrier and immune cell penetration by a photothermal microneedle for efficient anticancer therapy10.1021/acsami.1c06725 ↗
50. Responsive nanoplatforms: versatile design strategies for efficient cancer theranostics10.1016/j.matdes.2023.112076 ↗
51. Bilirubin nanoparticles as a nanomedicine for anti-inflammation therapy10.1002/anie.201602525 ↗
52. Multistimuli-responsive bilirubin nanoparticles for anticancer therapy10.1002/anie.201604858 ↗
53. A self-activating nanovesicle with oxygen-depleting capability for efficient hypoxia-responsive chemo-thermo cancer therapy10.1016/j.biomaterials.2020.120533 ↗
54. Glucose oxidase — an overview10.1016/j.biotechadv.2009.04.003 ↗
55. Biotinylated bilirubin nanoparticles as a tumor microenvironment-responsive drug delivery system for targeted cancer therapy10.1002/advs.201800017 ↗
56. Bilirubin nanomedicine rescues intestinal barrier destruction and restores mucosal immunity in colitis10.1021/acsnano.3c03252 ↗
57. Polylysine-bilirubin conjugates maintain functional islets and promote M2 macrophage polarization10.1016/j.actbio.2020.12.047 ↗
58. Synthesis and characterization of PVP microneedle patch using metal bioelectrodes for novel drug delivery system10.1016/j.matdes.2021.109485 ↗
59. Programmable polymeric microneedles for combined chemotherapy and antioxidative treatment of rheumatoid arthritis10.1021/acsami.1c17375 ↗
60. Frozen reinforced microneedles loaded with NIR-photothermal nanozyme for keratitis treatment10.1016/j.nantod.2023.102000 ↗
61. Self-responsive H2-releasing microneedle patch temporally adapts to the sequential microenvironment requirements for optimal diabetic wound healing10.1016/j.cej.2024.151200 ↗
62. Novel metal polyphenol framework for mr imaging-guided photothermal therapy10.1021/acsami.7b16222 ↗
63. Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy10.1016/j.jconrel.2017.10.021 ↗